Shanhe Pharmaceutical: Plans to invest 1.05 billion yuan to build a high-end auxiliary material smart manufacturing base.

Shanhe Pharmaceutical announced that the company signed the "High-end Excipient Intelligent Manufacturing Base Project Investment Agreement" with the Management Committee of Huainan Economic and Technological Development Zone. The total investment of the project is 1.05 billion yuan, with a fixed asset investment of 600 million yuan, to be built in two phases. The first phase will invest 450 million yuan, covering an area of 100 acres, and is expected to be completed and put into production within 24 months; the second phase will reserve 100 acres, with a total investment of 600 million yuan. The project includes high-end excipient intelligent production lines, quality inspection, environmental protection facilities, etc. The project covers approximately 200 acres of land, located north of Jialan Road, south of Changfu Road, east of Huaxing Road, and west of Luojiu Road in the Development Zone. The project funds come from own funds, bank loans, equity financing, etc. It is expected that it will not have a significant impact on the company's operating income and net profit for the reporting period in 2025.